scPharmaceuticals Inc.
SCPH · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 36.5% | -3.3% | 21.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 68.8% | 70.5% | 67.4% | 67% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -103.2% | -155.7% | -142.4% | -331.6% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -112.4% | -168% | -155.1% | -350.1% |
| EPS Diluted | -0.34 | -0.37 | -0.42 | -0.75 |
| % Growth | 8.1% | 11.9% | 44% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |